1RU.F Medartis Holding AG
- Market cap
- EUR 1.46B
- P/E
- 90.0x
- P/B
- 4.72x
- ROE
- 3.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 1RU.F undervalued?
Graham numberThe Graham number of Medartis Holding AG cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Medartis Holding AG fundamental analysis
No fundamental analysis for Medartis Holding AG yet.
Medartis Holding AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Medartis Holding AG
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under…
Full company profileMedartis Holding AG financial statements
Medartis Holding AG annual financial statements (CHF; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 160M | 183M | 212M | 225M | 269M |
| Gross Profit | 134M | 149M | 168M | 179M | 204M |
| Operating Income | 11.0M | -1.87M | 8.32M | 7.23M | 1.93M |
| EBITDA | - | 11.7M | 25.4M | 30.2M | 45.7M |
| Net Income | 6.84M | -5.78M | 619K | 3.53M | 8.35M |
| EPS | 0.58 | -0.49 | 0.05 | 0.28 | 0.67 |
| Balance Sheet | |||||
| Total Assets | 298M | 328M | 350M | 460M | 560M |
| Total Liabilities | 74.2M | 90.1M | 94.6M | 190M | 284M |
| Shareholders' Equity | 224M | 238M | 255M | 270M | 276M |
| Cash & Short-term Investments | 82.6M | 20.6M | 25.2M | 139M | 33.0M |
| Cash Flow | |||||
| Operating Cash Flow | 21.0M | -3.93M | 20.0M | 32.1M | 34.8M |
| Capital Expenditure | 10.4M | 18.8M | 18.8M | 11.1M | 25.5M |
| Free Cash Flow | 10.6M | -22.7M | 1.17M | 21.0M | 9.34M |
| Ratios | |||||
| ROE | 3.1% | -2.4% | 0.2% | 1.3% | 3.0% |
| ROA | 2.3% | -1.8% | 0.2% | 0.8% | 1.5% |
| Net Profit Margin | 4.3% | -3.2% | 0.3% | 1.6% | 3.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Medartis Holding AG dividends
Medartis Holding AG has not paid dividends in the last 5 fiscal years.
Who owns Medartis Holding AG
- Insiders 58.44%
- Institutions 27.78%
- Public & others 13.78%
- Shares outstanding 12.4M
- Free float 4.69M
Medartis Holding AG company profile
- Company name
- Medartis Holding AG
- Ticker
- 1RU.F
- ISIN
- CH0386200239
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 1,428
- Fiscal year end
- December
- Address
- Hochbergerstrasse 60E, Basel, Switzerland, 4057
- Phone
- 41 61 633 34 34
- Website
- medartis.com
About Medartis Holding AG
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.
Medartis Holding AG management
9- Mr. Matthias SchuppCEO & Member of the Executive Management Board · born 1964
- Dr. Thomas StraumannFounder & Vice Chairman · born 1963
- Dr. Peter Hackel Ph.D.CFO & Member of Executive Management Board · born 1969
- Ms. Mareike LochPresident of EMEA & Member of Executive Management Board · born 1970
- Mr. Mario Della CasaCOO & Member of Management Board · born 1975
- Mr. David ThoniPresident of US & Member of Executive Management Board · born 1965
- Ms. Caroline KnoeriChief Human Resources Officer & Executive Management Board Member · born 1975
- Mr. Marc AmmannExecutive Vice President of R&D and Innovation and Member of the Executive Management Board · born 1978
- Ms. Anisha WhartonHead of Regulatory Affairs